A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
Wenham, Robert M., Lapolla, James, Lin, Hui-Yi, Apte, Sachin M., Lancaster, Johnathan M., Judson, Patricia L., Gonzalez-Bosquet, Jesus, Herschberger, Amber, Havrilesky, Laura J., Secord, Angeles AlvarVolume:
130
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2013.04.049
Date:
July, 2013
File:
PDF, 311 KB
english, 2013